DAIRY PRIDE Act
Sponsored By: Senator Baldwin, Tammy [D-WI]
Introduced
Summary
Protects dairy identity terms by preventing non-dairy foods from using standardized dairy names in interstate commerce unless they meet federal dairy identity or imitation rules. It would add a new misbranding subsection to the Federal Food, Drug, and Cosmetic Act, define "dairy product", and set deadlines for FDA guidance and a Congress report on enforcement.
Show full summary
- Families and shoppers: Helps shoppers know when a product actually contains dairy by limiting the use of milk, cheese, or yogurt names to foods that meet federal dairy definitions.
- Dairy producers: Strengthens protections for dairy producers by restricting competitors from labeling non-dairy products with standardized dairy identity terms.
- Plant-based and alternative food makers: Would require products that use dairy names but do not meet the new dairy definition to change their labels or names or meet the dairy standards.
- FDA and enforcement: Directs the Secretary of Health and Human Services, acting through the FDA Commissioner, to issue draft guidance within 90 days and final guidance within 180 days, and to report to Congress within 2 years on warnings, penalties, and an updated enforcement plan if misbranded foods remain offered interstate.
Personalized for You
How does this bill affect your finances?
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
1 provisions identified: 0 benefits, 0 costs, 1 mixed.
New rules on dairy names
This bill would ban using standard dairy product names on foods that do not meet federal dairy identity rules. A food could use a dairy name only if it is made from milk of hooved mammals. Or it could meet the federal rules for imitation foods. The FDA would have 90 days after enactment to publish draft guidance and 180 days for final guidance. Within two years, FDA would report to Congress on enforcement actions, warnings, and penalties and update its enforcement plan if needed.
Sponsors & CoSponsors
Sponsor
Baldwin, Tammy [D-WI]
WI • D
Cosponsors
Sen. Risch, James E. [R-ID]
ID • R
Sponsored 7/29/2025
Sen. Collins, Susan M. [R-ME]
ME • R
Sponsored 7/29/2025
Sen. Welch, Peter [D-VT]
VT • D
Sponsored 7/29/2025
Sen. Klobuchar, Amy [D-MN]
MN • D
Sponsored 7/29/2025
Sen. King, Angus S., Jr. [I-ME]
ME • I
Sponsored 7/29/2025
Sen. Fetterman, John [D-PA]
PA • D
Sponsored 7/29/2025
Sen. Gillibrand, Kirsten E. [D-NY]
NY • D
Sponsored 7/29/2025
Sen. Crapo, Mike [R-ID]
ID • R
Sponsored 7/29/2025
Sen. Rounds, Mike [R-SD]
SD • R
Sponsored 7/29/2025
Sen. Ricketts, Pete [R-NE]
NE • R
Sponsored 7/29/2025
Sen. Marshall, Roger [R-KS]
KS • R
Sponsored 7/29/2025
Sen. Smith, Tina [D-MN]
MN • D
Sponsored 7/29/2025
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov